Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Treatment Drugs. This report contains market size and forecasts of Prostate Cancer Treatment Drugs in global, including the following market information:
Global Prostate Cancer Treatment Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Asia Pacific is anticipated to be the fastest growing market over the forecast period. Rising awareness of such tumors would primarily drive growth. Governments of various countries in this region are playing a vital role in creating awareness through programs and online portals that provide detailed information regarding screening & diagnosis through PSA blood tests and DRE for male patients over 50 years of age.
We surveyed the Prostate Cancer Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Treatment Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Prostate Cancer Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others
Global Prostate Cancer Treatment Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Prostate Cancer Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Clinics
Global Prostate Cancer Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Prostate Cancer Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Treatment Drugs, market overview.
Chapter 2: Global Prostate Cancer Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Treatment Drugs Overall Market Size
2.1 Global Prostate Cancer Treatment Drugs Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Treatment Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Treatment Drugs Players in Global Market
3.2 Top Global Prostate Cancer Treatment Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Treatment Drugs Market Size Markets, 2022 & 2030
4.1.2 Zytiga
4.1.3 Gonax
4.1.4 Lupron
4.1.5 Zoladex
4.1.6 Decapeptyl
4.1.7 Eligard
4.1.8 Vantas
4.1.9 Casodex
4.1.10 Others
4.2 By Type - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Treatment Drugs Revenue, 2024-2030
4.2.3 By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Treatment Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Clinics
5.2 By Application - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Treatment Drugs Revenue, 2024-2030
5.2.3 By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Treatment Drugs Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Treatment Drugs Revenue, 2024-2030
6.2.3 By Region - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.3.2 US Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.3 France Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.5.2 China Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.6 India Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Treatment Drugs Market Size, 2018-2030
7 Prostate Cancer Treatment Drugs Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Major Product Offerings
7.1.4 Johnson & Johnson Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Astella
7.2.1 Astella Company Summary
7.2.2 Astella Business Overview
7.2.3 Astella Prostate Cancer Treatment Drugs Major Product Offerings
7.2.4 Astella Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Astella Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prostate Cancer Treatment Drugs Major Product Offerings
7.3.4 Sanofi Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Ipsen
7.4.1 Ipsen Company Summary
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Prostate Cancer Treatment Drugs Major Product Offerings
7.4.4 Ipsen Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Ipsen Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Prostate Cancer Treatment Drugs Major Product Offerings
7.5.4 Bayer Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Prostate Cancer Treatment Drugs Major Product Offerings
7.6.4 AstraZeneca Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Dendreon
7.7.1 Dendreon Company Summary
7.7.2 Dendreon Business Overview
7.7.3 Dendreon Prostate Cancer Treatment Drugs Major Product Offerings
7.7.4 Dendreon Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Dendreon Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Treatment Drugs Market Drivers in Global Market
Table 3. Prostate Cancer Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Treatment Drugs in Global Market
Table 5. Top Prostate Cancer Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Treatment Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prostate Cancer Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Treatment Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Prostate Cancer Treatment Drugs Product Offerings
Table 32. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Astella Company Summary
Table 35. Astella Prostate Cancer Treatment Drugs Product Offerings
Table 36. Astella Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Astella Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Prostate Cancer Treatment Drugs Product Offerings
Table 40. Sanofi Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Ipsen Company Summary
Table 43. Ipsen Prostate Cancer Treatment Drugs Product Offerings
Table 44. Ipsen Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Ipsen Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Prostate Cancer Treatment Drugs Product Offerings
Table 48. Bayer Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Prostate Cancer Treatment Drugs Product Offerings
Table 52. AstraZeneca Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Dendreon Company Summary
Table 55. Dendreon Prostate Cancer Treatment Drugs Product Offerings
Table 56. Dendreon Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Dendreon Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Treatment Drugs Segment by Type in 2022
Figure 2. Prostate Cancer Treatment Drugs Segment by Application in 2022
Figure 3. Global Prostate Cancer Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Treatment Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Treatment Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 16. US Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 28. China Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astella Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ipsen Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dendreon Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
